Hepatitis B og C
-
HCV guidelines 2022v2
National guideline udarbejdet af en arbejdsgruppe nedsat af medlemmer fra Dansk Selskab for Infektionsmedicin og medlemmer fra Dansk Selskab for Gastroenterologi og Hepatologi.
Aktuelle version 1. april 2026 med opdaterede regimer til ubehandlede patienter med alle grader af fibrose inklusive Child-Pugh A cirrose, se også medicinraadet.dk/anbefalinger-og-vejledninger/behandlingsvejledninger-og-laegemiddelrekommandationer/kronisk-hepatitis-c
-
Hepatitis B (2025)Version 9.
Udarbejdet af en arbejdsgruppe nedsat af Dansk Selskab for Infektionsmedicin og Dansk Selskab for Gastroenterologi og Hepatologi.
-
Screening før behandling med biologiske og målrettede syntetiske lægemidler (2023)
-
Retningslinjer for screening og profylakse før behandling med biologiske lægemidler (2023)Omhandler biologiske og målrettede syntetiske lægemidler (BMSL) til patienter i forhold til risiko for tuberkulose (TB), Humant Papillom Virus (HPV), Hepatitis B og C (HBV og HCV), Varicella Zoster Virus (VZV), Herpes Simplex Virus (HSV), Cytomegalovirus (CMV), Epstein Barr Virus (EBV) og Humant Immundefekt Virus (HIV) og øvrige infektioner.
Vejledningen er udarbejdet af repræsentanter fra Dansk Selskab for Gastroenterologi og Hepatologi (DSGH), Dansk Reumatologisk Selskab (DRS), Dansk Dermatologisk Selskab (DDS) og Dansk Selskab for Infektionsmedicin (DSI).
-
REACH-B Score for Hepatocellular Carcinoma (MDCalc)
https://www.mdcalc.com/calc/10031/reach-b-score-hepatocellular-carcinoma-hcc
-
PYHIN proteins: guardians or contributors to hepatitis B virus pathogenesis?Frontiers in ImmunologyTilføjet 18. september 2026
-
HIV and Hepatitis B co-infection in Tanzania: Analysis of the 2022–2023 Tanzania HIV Impact SurveyPLoS One Infectious DiseasesTilføjet 13. september 2026
-
Chronic hepatitis B and perioperative chemotherapy efficacy in colorectal liver metastases: an exploratory analysis of clinical and mechanistic evidenceFrontiers in ImmunologyTilføjet 5. september 2026
-
Shenling Baizhu powder alleviates non-alcoholic steatohepatitis by reducing PPARα-mediated NLRP3 inflammasome activationFrontiers in ImmunologyTilføjet 20. august 2026
-
The “viral–metabolic” interaction mechanisms and management challenges in chronic hepatitis B combined with metabolic dysfunction-associated fatty liver disease: from clinical evidence to an integrated multidisciplinary frameworkFrontiers in ImmunologyTilføjet 20. august 2026
-
Identification of novel HLA class I-restricted hepatitis B virus peptides and their modulation by peptide editor TAPBPRFrontiers in ImmunologyTilføjet 1. august 2026
-
Correction: Modelling Hepatitis B virus related hospital discharges in Spain: ARIMAX based liver disease forecasting tool for hospital workload and mortality progressionPLoS One Infectious DiseasesTilføjet 18. juli 2026
-
An umbrella review navigating the nationwide burden of hepatitis B virus infection in Ethiopia: A call for action on vaccination, safe blood, and infection preventionPLoS One Infectious DiseasesTilføjet 23. juni 2026
-
Hepatitis B Core‐Related Antigen Level Predicts Disease Progression in the Gray Zone Hepatitis B PatientsJournal of Medical VirologyTilføjet 10. april 2026
-
Impact of Hepatitis B Exposure and/or HIV Co‐Infection on Clinical Outcomes in Chronic Hepatitis C Patients in Oman: An Ambidirectional Cohort StudyJournal of Medical VirologyTilføjet 10. april 2026
-
Burden of human immunodeficiency virus and hepatitis B and C viruses in incoming Venezuelan migrants at the Colombian border: a laboratory-based cross-sectional study, 2021-2023Clinical Microbiology and InfectionTilføjet 8. april 2026
-
Multimorbidity patterns and their associations with healthcare services utilisation in inpatients with chronic hepatitis B infection from 2011 to 2023: a retrospective observational studyBMJ OpenTilføjet 7. april 2026
-
Pregenomic RNA as a Marker for Monitoring Disease Prognosis and Viral Relapse in Hepatitis B Patients on Long‐Term Antiviral Therapy: A Systematic Review and Meta‐AnalysisJournal of Medical VirologyTilføjet 20. marts 2026
-
Expression of Concern: Seroepidemiology and associated risk factors of hepatitis B and C virus infections among pregnant women attending maternity wards at two hospitals in Swabi, Khyber Pakhtunkhwa, PakistanPLoS One Infectious DiseasesTilføjet 20. marts 2026
-
Serum sIL-2R Predicts Significant Histological Disease in Indeterminate Phase Chronic Hepatitis BInternational Journal of Infectious DiseasesTilføjet 19. marts 2026
-
Impact of Metabolic Associated Steatotic Liver Disease on Antiviral Therapy Outcomes on Chronic Hepatitis B Patients Receiving Antiviral TherapyJournal of Medical VirologyTilføjet 20. marts 2026
-
The Cost-Effectiveness of Universal Hepatitis B Screening in VietnamInternational Journal of Infectious DiseasesTilføjet 19. marts 2026
-
A Genetic Variant of TLR6 Predicts HBsAg Decline After Pegylated Interferon‐Alpha Treatment in HBeAg‐Positive Chronic Hepatitis BJournal of Medical VirologyTilføjet 15. marts 2026
-
Hepatitis B virus infection and its determinants among pregnant women in Ethiopia: protocol for umbrella review of systematic review and meta-analysis 2025BMJ OpenTilføjet 4. marts 2026
-
Hepatitis B Vaccination Coverage and Vaccine‐Associated Immunity Among US‐Born Children and Adolescents: NHANES 2017–2020Journal of Medical VirologyTilføjet 23. februar 2026